A bill that would allow anti-choking devices in K-12 schools across Kentucky has traction in the General Assembly. But first-aid experts warn, and research shows, the devices are not reliably ...
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Pursuing dangerous Medicaid block grant schemes and allowing flagrant violations of unequivocal state laws looks like ...
BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...
2d
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
A team of researchers at the Medical University of South Carolina has discovered that a commonly used drug, N-acetylcysteine (NAC), could help reduce pain after surgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback